Related Experiment Video
Updated: Aug 23, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Evaluation of Pulmonary Functions After Discharge in Pediatric Patients with COVID-19: A Prospective Study
Sevcan Ipek1, Sukru Gungor2, Ufuk Utku Gullu3
1Department of Pediatrics, Kahramanmaraş Sütçü İmam University Medical Faculty, Kahramanmaraş, Türkiye.
Insights
Pediatric patients recovering from COVID-19 showed abnormal pulmonary function tests (PFTs), indicating potential mixed-type lung disease. Further research is needed to understand long-term outcomes in these children.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Respiratory Medicine
Background:
- COVID-19 can affect multiple organ systems, including the lungs.
- Long-term respiratory sequelae in pediatric COVID-19 survivors are not fully understood.
- Assessing pulmonary function post-infection is crucial for evaluating recovery and potential complications.
Purpose of the Study:
- To investigate pulmonary function in pediatric patients after recovery from COVID-19.
- To compare spirometry results between recovered pediatric COVID-19 patients and a healthy control group.
- To identify potential respiratory abnormalities and their characteristics in this population.
Main Methods:
- A prospective study included pediatric patients (5-18 years) hospitalized with COVID-19 and discharged after recovery.
- Pulmonary function tests (PFTs) were conducted using spirometry.
- Results were compared between the patient group (n=34) and a control group (n=33).
Main Results:
- Pediatric patients exhibited significantly lower forced vital capacity (FVC%) and forced expiratory volume in the first second (FEV1%) compared to controls.
- FEV1/FVC% was also significantly reduced in the patient group.
- Forced expiratory flow (FEF) 25-75% showed no significant difference, but a moderate negative correlation with hospital stay length was observed.
Conclusions:
- Pulmonary function tests revealed abnormalities in pediatric patients after recovering from COVID-19.
- The findings suggest a potential development of mixed-type lung disease.
- Further long-term and short-term studies are essential to fully understand the prognosis for these patients.
Objectives:
The aim of this study was to investigate the pulmonary function of pediatric patients with COVID-19 after recovery.
Methods:
Pediatric patients aged 5-18 years hospitalized with diagnoses of COVID-19 and discharged with recovery were included in this prospective study. Pulmonary function tests (PFTs) were performed through spirometry.
Results:
The patient group consisted of 34 children and the control group of 33. The forced vital capacity (FVC%) values of the control and patient groups were 110.62±11.71 and 94.21±13.68 (p<0.001), forced expiratory volume in the first second (FEV1%) values were 104.91±6.26 and 98.67±14.93 (p=0.032), FEV1/FVC% values were 108.50±8.81 and 101.06±24.89 (p=0.034), and forced expiratory flow (FEF) 25-75% values were 106.71±6.68 and 101.85±24.89, respectively (p=0.286). However, Spearman correlation analysis revealed moderate negative correlation between length of hospital stay and FEF 25-75% (r=-0.364, p=0.35).
Conclusion:
PFTs in pediatric patients after recovery from COVID-19 were abnormal in the present study. The results were significant in terms of the development of mixed-type lung disease. Further long- and short-term studies are now needed for a better understanding of the prognosis in these patients.
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

